Using a staining index of 5 as the cutoff point in the 233 patients with NPC examined, we classified 166 (71.2%) patients with low expression of Talin-1 and 67 (28.8%) patients with high expression of Talin-1. This evidence concerns the gene TLN1 and nasopharyngeal carcinoma.